Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1.

Liu SS, Wang YR, Gu SM, Li YQ, Li YR, Zhang NN, Tie L, Yang BX, Pan Y, Li XJ

DOI: 10.1038/s41401-026-01754-4
Published: 2026 Jun
Container: Acta pharmacologica Sinica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41401-026-01754-4,
  title = {Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1.},
  author = {Liu SS and Wang YR and Gu SM and Li YQ and Li YR and Zhang NN and Tie L and Yang BX and Pan Y and Li XJ},
  year = {2026},
  journal = {Acta pharmacologica Sinica},
  doi = {10.1038/s41401-026-01754-4},
  url = {https://doi.org/10.1038/s41401-026-01754-4}
}

RIS

TY  - JOUR
TI  - Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1.
AU  - Liu SS
AU  - Wang YR
AU  - Gu SM
AU  - Li YQ
AU  - Li YR
AU  - Zhang NN
AU  - Tie L
AU  - Yang BX
AU  - Pan Y
AU  - Li XJ
PY  - 2026
JO  - Acta pharmacologica Sinica
DO  - 10.1038/s41401-026-01754-4
UR  - https://doi.org/10.1038/s41401-026-01754-4
ER  -

APA

SS, L., YR, W., SM, G., YQ, L., YR, L., NN, Z., L, T., BX, Y., Y, P., & XJ, L. (2026). Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1.. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01754-4

Source records

pubmed · retrieved 2026-09-25T22:19:15.196Z